include"/home2/www/vhosts/terradaily.com/tdxphp/tdxphp-start.php" ?>
Scientists Develop SARS Vaccine![]() illustration only |
The researchers at the school's Virginia-Maryland Regional College of Veterinary Medicine engineered a recombinant Newcastle Disease virus, or NDV, an avian paramyxovirus, to create a vaccine that holds promise to protect humans against multiple diseases.
"The Newcastle Disease virus makes a very good vector for creating human vaccines," said Siba Samal, the research team leader and VMRCVM associate dean.
"NDV replicates in species other than poultry, but not enough to cause disease. Also, there are nine types of paramyxoviruses and NDV is Serotype 1, so we can make similar vaccine vectors with other avian paramyxovirus types, which can be used to protect against more than one disease."
The study was presented last month during the International Conference on Negative Strand Viruses in Salamanca, Spain.
Related Links
Le Bugue, France (UPI) Jul 20, 2006| The content herein, unless otherwise known to be public domain, are Copyright 1995-2006 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA PortalReports are copyright European Space Agency. All NASA sourced material is public domain. Additionalcopyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |